Press releases

  • Banks Do too Little to Communicate Their Sustainable Investment Products

    More and more private banks are offering sustainable investment options to wealthy clients. How do these products differ from one another? And do the banks' advisory services meet the expectations of investors? A study by the University of Zurich into the products and services of the 15 leading European private banks shows that most still have room for improvement.

  • Number of Students at UZH Remains High

    Around 26,500 students have enrolled for the Fall Semester 2018, with the University of Zurich registering a slight increase in the Faculty of Science and the Faculty of Medicine as well as in the number of Master's students. The University Program for School Students has got off to a good start with some 40 registrations.

  • Special Antibodies Could Lead to HIV Vaccine

    Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the University of Zurich and the University Hospital Zurich have now shown that the genome of the HI virus is a decisive factor in determining which antibodies are formed.

  • B Cells Among Factors Leading to Brain Lesions in Multiple Sclerosis

    A team of researchers the University of Zurich and the University Hospital Zurich has shown that in multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain. B cells, a different type of immune cell, also play a role. These cells activate T cells in the blood. This discovery explains how new MS drugs take effect, opening up novel options for treating the disease.

  • Dreaming of Flying

    How does it feel to fly like a bird? What happens when our heart skips a beat? The varied new program of the Children’s University begins in the Fall Semester 2018.

  • Protein Modifications that Point to Cancer

    Researchers from the University of Zurich can, for the first time, precisely characterize the protein modification ADP-ribosylation for all proteins in a tissue sample. The changes, which are a typical reaction to stress, provide information about the condition of a cell. Together with the University Hospital Zurich, they are now testing the new method to diagnose and treat cancer.

  • Jupiter Had Growth Disorders

    Researchers of the Universities of Zurich and Bern and of ETH Zurich show how Jupiter was formed. Data collected from meteorites had indicated that the growth of the giant planet had been delayed for two million years. Now the researchers have found an explanation: Collisions with kilometer-sized blocks generated high energy, which meant that in this phase hardly any accretion of gas could take place and the planet could only grow slowly.

More communications